Clinical Trials Browser

Interventional × Colitis, Ulcerative × 1 year × Clear all

NCT03816345 2026-05-13

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Phase 1 Recruiting

Other hematologic neoplasm

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Dermatomyositis, Lupus Erythematosus, Systemic, Multiple Sclerosis, Psoriasis, Scleroderma, Systemic, Sjogren's Syndrome, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Hematologic Neoplasms

NCT05156125 2026-04-30

VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis

Phase 2 Terminated

213 enrolled 19 charts

Colitis, Ulcerative, Lymphoma, Follicular

NCT07223424 2026-04-16

PSI-Immune

Phase 2 Recruiting

DermatologicGastrointestinalGenitourinaryGynecologicThoracic

Adenocarcinoma Of Esophagus, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Colitis, Ulcerative, Colonic Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Melanoma

NCT07089771 2026-03-20

Virtual Versus Dye-based Chromoendoscopy in Inflammatory Bowel Disease Surveillance Colonoscopy

Phase NA Not yet recruiting

Gastrointestinal

Colitis, Ulcerative, Crohn Disease, Colorectal Neoplasms, Inflammatory Bowel Diseases

NCT04191655 2026-03-06

High Definition Colonoscopy (HDC) vs. Dye Spraying Chromo-colonoscopy (DSC) in Screening Patients With Long-standing Inflammatory Bowel Disease (IBD)

Phase NA Completed

Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases

NCT04767984 2026-01-21

Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis

Phase 2 Active not recruiting

Gastrointestinal

Colitis, Ulcerative, Colorectal Neoplasms

NCT07347158 2026-01-16

Effectiveness of Health Education as a Nursing Intervention in Improving Quality of Life and Reducing Symptoms of Anxiety and Depression in Ostomy Patients Following Digestive Surgery: A Quasi-Experimental Study.

Phase NA Enrolling by invitation

Gastrointestinal

Anxiety Disorders, Colitis, Ulcerative, Colonic Neoplasms, Depression, Health Education

NCT03760003 2025-11-28

Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis

Phase 2 Completed

355 enrolled 39 charts

Colitis, Ulcerative

NCT06881303 2025-11-18

RESTODIG

Phase NA Not yet recruiting

Gastrointestinal

Colitis, Ulcerative, Crohn Disease, Gastrointestinal Neoplasms, Adenomatous Polyposis Coli

NCT07113717 2025-08-11

POPHaH

Phase NA Not yet recruiting

Gastrointestinal

Colitis, Ulcerative, Colonic Neoplasms, Crohn Disease, Diverticulosis, Colonic

NCT06538402 2025-07-09

TESTIMONY

Phase NA Recruiting

Gastrointestinal

Colitis, Ulcerative, Adenomatous Polyposis Coli

NCT05785715 2025-07-01

Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis

Phase 2 Terminated

Colitis, Ulcerative, Lymphoma, Follicular